(Q48374918)

11 February 2018

review article

1 reference

title

Assessment and treatment of depression in the cancer patient. (English)

1 reference

11 February 2018

author name string

Newport DJ

series ordinal

1

1 reference

11 February 2018

Nemeroff CB

series ordinal

2

1 reference

11 February 2018

publication date

1 September 1998

1 reference

11 February 2018

Journal of Psychosomatic Research

number of pages

23

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

11 February 2018

volume

45

1 reference

11 February 2018

issue

3

1 reference

11 February 2018

page(s)

215-237

1 reference

11 February 2018

Depression in hospitalized cancer patients

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Depression and abnormal illness behavior in cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

The recognition of psychiatric morbidity on a medical oncology ward.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Comparative studies of psychological function in patients with advanced cancer--I. Self-reported depressive symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Stress and relapse of breast cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Identifying patients at risk for, and treatment of major psychiatric complications of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

The existential plight in cancer: significance of the first 100 days

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Factors associated with psychological distress in cancer patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Psychosocial status in chronic illness. A comparative analysis of six diagnostic groups.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Psychosocial morbidity and adjustment to illness among long-term cancer survivors. A six-year follow-up study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Maladaptive coping and affective disorders among cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Depression in the medically ill: an overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Psychosocial influences on cancer incidence and progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

The catecholamine hypothesis of affective disorders: a review of supporting evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Depressive Symptoms in Cancer Patients Undergoing Chemotherapy: A Psychometric Analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Clinical recognition and management of depression in node negative breast cancer patients treated with tamoxifen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Delirium and depression associated with amphotericin B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Beta-lipotropin-beta-endorphin response to low-dose ovine corticotropin releasing factor in endogenous depression. Preliminary studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Psychiatric morbidity and physical toxicity associated with adjuvant chemotherapy after mastectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Psychological response of patients receiving two drug regimens for lung carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Randomised trial of four-drug vs less intensive two-drug chemotherapy in the palliative treatment of patients with small-cell lung cancer (SCLC) and poor prognosis. Medical Research Council Lung Cancer Working Party

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Side effects and emotional distress during cancer chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Inhibition of release of dopamine- -hydroxylase and norepinephrine from sympathetic nerves by colchicine, vinblastine, or cytochalasin-B (hypogastric nerve stimulation-exocytosis-microtubules-microfilaments-guinea pig)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Further studies on the ex-vivo effects of procarbazine and monomethylhydrazine on rat semicarbazide-sensitive amine oxidase and monoamine oxidase activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Characteristics of procarbazine as an inhibitor in-vitro of rat semicarbazide-sensitive amine oxidase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

The psychological impact of cancer and cancer surgery. I. Adaptation to the dry colostomy; preliminary report and summary of findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Pre- and post-treatment sexual life in testicular cancer patients: a descriptive investigation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Psychological and social adjustment to mastectomy: a two-year follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Psychosocial adjustment among husbands of women treated for breast cancer; mastectomy vs. breast-conserving surgery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Psychiatric problems in the first year after mastectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Oat cell carcinoma with hypercortisolemia presenting to a psychiatric hospital as a suicide attempt.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Mental disorder associated with primary lung carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Behavioral manifestations of paraneoplastic encephalopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

"Limbic encephalitis" and its association with carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Neurological and cardiac complications of carcinoma of the breast. Case report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Cancer and Depression: Cancer Presenting with Depressive Illness: An Autoimmune Disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Neurogenic paraneoplastic syndromes. The brain's uneasy peace with tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Paraneoplastic syndromes: Unusual manifestations of malignant disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Psychopathology of pancreatic cancer. A psychobiologic probe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Excessive urinary 5-hydroxy-3-indole acetic acid in the absence of a metastatic carcinoid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Depressive disorders in the medically ill. An overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Are depressive symptoms nonspecific in patients with acute stroke?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Diagnosis of major depression in cancer patients according to four sets of criteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Diagnosing depression in patients with medical illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Detection of depressive disorder for patients receiving prepaid or fee-for-service care. Results from the Medical Outcomes Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Normal and pathological grief.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

A study of normal bereavement.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

The first year of bereavement. A longitudinal study of the reaction of London widows to the death of their husbands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Diagnosing depression in the hospitalized medically ill

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Measurement of depression in patients with cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

A successful psychiatric training program for medical residents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Unsuspected emotional and cognitive disturbance in medical patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Prevalence by Self-report questionnaire and recognition by nonpsychiatric physicians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Assessing depression in primary medical and psychiatric practices.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Underrecognition of patients' psychosocial distress in a university hospital medical clinic.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Medication noncompliance: systematic approaches to evaluation and intervention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

A brief depression scale for use in the medically ill

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Survival and health care utilization in elderly medical inpatients with major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Suicidal Behavior in Chronic Dialysis Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

The long-term outcome of psychiatric morbidity detected in general medical patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Increased mortality rates in late-life depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Stopping life-sustaining medical treatment: psychiatric considerations in the termination of renal dialysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Adrenal cortical activity in depressive illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Cortisol production in depressive illness. A clinical and biochemical clarification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Pituitary-adrenal function in depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

The oCRH stimulation test before and after clinical recovery from depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Adrenal gland enlargement in major depression. A computed tomographic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Adrenal gland volume in major depression. Increase during the depressive episode and decrease with successful treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Adrenal weight and morphology in victims of completed suicide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Increased adrenal weight in victims of violent suicide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Pituitary size in depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

The dexamethasone suppression test and depression. Approaches to the use of a laboratory test in psychiatry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

The dexamethasone suppression test for diagnosis and prognosis in psychiatry. Commentary and review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

What does the dexamethasone suppression test identify?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Hypothalamic-pituitary-adrenal axis and suicide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

CSF corticotropin-releasing factor-like immunoactivity in chronic pain patients with and without major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Assessment of adrenal gland volume by computed tomography in depressed patients and healthy volunteers: a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Psychiatric implications of basic and clinical studies with corticotropin-releasing factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Blunted Corticotropin and Normal Cortisol Response to Human Corticotropin-Releasing Factor in Depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Consistent reduction of ACTH responses to stimulation with CRH, vasopressin and hypoglycaemia in patients with major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Neuropeptide concentrations in the cerebrospinal fluid of depressed patients treated with electroconvulsive therapy. Corticotrophin-releasing factor, beta-endorphin and somatostatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Effect of desipramine on cerebrospinal fluid concentrations of corticotropin-releasing factor in human subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Newer antidepressants and the cytochrome P450 system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Depression in women treated for gynecological cancer: clinical and neuroendocrine assessment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Depression and carcinoma of the pancreas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Elevated basal cortisol levels and attenuated ACTH and cortisol responses to a behavioral challenge in women with metastatic breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Psychological disturbance alters thymic and adrenal hormone secretion in a parallel but independent manner.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Psychoneuroimmunology: animal models of disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Correlation of stress factors with sustained depression of natural killer cell activity and predicted prognosis in patients with breast cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Perceived social support and tumor estrogen/progesterone receptor status as predictors of natural killer cell activity in breast cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Evidence for an immune response in major depression: a review and hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Immunoendocrine aspects of major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

The monocyte-T-lymphocyte hypothesis of major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Indicators of immune activation in major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Changes in immunoglobulin, complement and acute phase protein levels in the depressed patients and normal controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Hypothesis: cytokines may be activated to cause depressive illness and chronic fatigue syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Neuropeptide innervation of lymphoid organs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Neuroendocrine-immune interactions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Noradrenergic sympathetic neural interactions with the immune system: structure and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Involvement of peripheral and central catecholamine systems in neural-immune interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Interleukin-1 alpha induces corticotropin-releasing factor secretion and synthesis from NPLC-KC cells through various second messenger pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Interleukin-1 directly stimulates the release of corticotrophin releasing factor from rat hypothalamus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Central corticotropin-releasing factor suppresses natural killer cytotoxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Central corticotropin-releasing hormone reduces cellular immunity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Cytokine production and serum proteins in depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

The immune system and major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Stress increases metastatic spread of a mammary tumor in rats: evidence for mediation by the immune system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Increased pulmonary metastases and natural killer cell activity in mice following handling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Morphine attenuates surgery-induced enhancement of metastatic colonization in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Psychosocial modulation of cytokine-induced natural killer cell activity in older adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Depression, stressful events and the risk of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

A structured psychiatric intervention for cancer patients. I. Changes over time in methods of coping and affective disturbance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

A structured psychiatric intervention for cancer patients. II. Changes over time in immunological measures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Effect of psychosocial treatment on survival of patients with metastatic breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Group support for patients with metastatic cancer. A randomized outcome study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Supportive telephone intervention for patients receiving chemotherapy. A pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Group psychological therapy for cancer patients: a point of view, and discussion of the hierarchy of options

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

A model for psychotherapy with the good-prognosis cancer patient. Conducted at a time when the patient is amenable to change

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Hypnosis on a consultation-liaison service

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Group therapy with the terminally ill

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

The effect of compliance with treatment on survival among patients with hematologic malignancies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Group psychotherapy during radiotherapy: effects on emotional and physical distress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Psychotropic drug use in the medically ill: Part I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Treatment of depression in cancer patients is associated with better life adaptation: a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Withdrawn, Apathetic Geriatric Patients Responsive to Methylphenidate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Double-blind, placebo-controlled trial of methylphenidate in older, depressed, medically ill patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Methylphenidate hydrochloride as an antidepressant: controversy, case studies, and review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Psychostimulants for depression in hospitalized cancer patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Long-term methylphenidate use in the medically ill patient with organic mood syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Use of stimulants in the medically ill.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

New antidepressant drugs and the treatment of depression in the medically ill patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

The role of human cytochrome P450 enzymes in the metabolism of anticancer agents: implications for drug interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Comparison of psychiatric symptoms in carcinoma of the pancreas with those in some other intra-abdominal neoplasms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Comparative psychological disturbance in patients with pancreatic and gastric cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Quality of life in treated head and neck cancer patients: a preliminary report.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Depression and anxiety in patients undergoing diagnostic investigations for head and neck cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Psychosocial aspects of neoplastic disease: II. Affective and cognitive effects of chemotherapy in cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Psychological outcomes of different treatment policies in women with early breast cancer outside a clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Psychiatric morbidity in patients with advanced cancer of the breast: prevalence measured by two self-rating questionnaires

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Screening for psychiatric morbidity in patients with advanced breast cancer: validation of two self-report questionnaires

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Psychiatric disorder in patients with advanced breast cancer: prevalence and associated factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

The emotional status of cancer patients as measured by a psychological test.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Depressed mood and other variables related to bone marrow transplantation survival in acute leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Screening for adjustment disorders and major depressive disorders in cancer in-patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Depression and immunity: a meta-analytic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

Pemoline. An alternative psychostimulant for the management of depressive disorders in cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Efficacy of psychosocial intervention with cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900011-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3999(98)00011-7

1 reference

11 February 2018

PubMed ID

9776368

1 reference

11 February 2018